Melatonin in humans

New England Journal of Medicine

Volumn 336, Issue 3, 1997, Pages 186-195

  Brzezinski, Amnon ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

AFFECTIVE NEUROSIS; AGING; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL PROTECTION; CIRCADIAN RHYTHM; FEMALE INFERTILITY; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HUMAN; HYPNOSIS; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNOREGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SLEEP PATTERN; STEROIDOGENESIS;

AGING; ANIMALS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; NEOPLASMS; PINEAL GLAND; PUBERTY; RECEPTORS, CELL SURFACE; REPRODUCTION; SLEEP;

EID: 0031021914     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199701163360306     Document Type: Review

References (89)

1. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958;80:2587.
2. Axelrod J, Weissbach H. Enzymatic O-methylation of N-acetylserotonin to melatonin. Science 1960;131:1312-3.
3. Coon SL, Roseboom PH, Baler R, et al. Pineal serotonin N-acetyltransferase: expression cloning and molecular analysis. Science 1995;270:1681-3.
4. Fung BK. Transducin: structure, function, and role in phototransduction. In: Osborne NN, Chader GJ, eds. Progress in retinal research. Vol. 6. Oxford, England: Pergamon Press, 1987:151-77.
5. Pangerl B, Pangerl A, Reiter RJ. Orcadian variations of adrenergic receptors in the mammalian pineal gland: a review. J Neural Transm Gen Sect 1990;81:17-29.
6. Waldhauser F, Weiszenbacher G, Frisch H, Zeitlhuber U, Waldhauser M, Wurtman RJ. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet 1984;1:362-5.
7. Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH. Daily rhythm in human urinary melatonin. Science 1975;187:169-71
8. Waldhauser F, Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann N Y Acad Sci 1985;453:205-14.
9. Reppert SM, Weaver DR, Rivkees SA, Stopa EG. Putative melatonin receptors in a human biological clock. Science 1988;242:78-81.
10. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980;210:1267-9.
11. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Quantal melatonin suppression by exposure to low intensity light in man. Life Sci 1989;45:327-32.
12. Czeisler CA, Shanahan TL, Klerman EB, et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 1995;332:6-11.
13. Iguchi H, Kato KI, Ibayashi Y. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab 1982;54:1025-7.
14. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984;39:307-13.
15. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A 1994;91:1824-8.
16. Nordlund JJ, Lerner AB. The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab 1977; 45:768-74.
17. Wright JM, Aldhous M, Franey C, English J, Arendt J. The effects of exogenous melatonin on endocrine function in man. Clin Endocrinol (Oxf) 1986;24:375-82.
18. Morgan PJ, Barrett P, Howell HE, Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994;24:101-46.
19. Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995;16:50-6.
20. Ebisawa T, Karne S, Lerner MR, Reppert SM. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci U S A 1994;91:6133-7.
21. Reppert SM, Weaver DR, Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994;13:1177-85.
22. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A 1995;92:8734-8.
23. Benitez-King G, Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia 1993;49:635-41.
24. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994;269:28531-4.
25. Stankov B, Fraschini F, Reiter RJ. Melatonin binding sites in the central nervous system. Brain Res Brain Rev 1991;16:245-56.
26. Lee PPN, Pang SF. Melatonin and its receptors in the gastrointestinal tract. Biol Signals 1993;2:181-93.
27. Yie SM, Niles LP, Younglai EV. Melatonin receptors on human granulosa cell membranes. J Clin Endocrinol Metab 1995;80:1747-9.
28. Viswanathan M, Laitinen JT, Saavedra JM. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci U S A 1990;87:6200-3.
29. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
30. Tan DX, Poeggeler B, Reiter RJ, et al. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993;70:65-71.
31. Reiter RJ. The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem Int 1995;27:453-60.
32. Maestroni GJ. The immunoneuroendocrine role of melatonin. J Pineal Res 1993;14:1-10.
33. Maestroni GJM, Conti A, Lissoni P. Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. Cancer Res 1994;54:4740-3.
34. Maestroni GJM, Covacci V, Conti A. A hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res 1994;54:2429-32.
35. Gonzales-Haba MG, Garcia-Maurino S, Calvo JR, Goberna R, Guerrero JM. High-affinity binding of melatonin by human circulating T lymphocytes (CD4+). FASEB J 1995;9:1331-5.
36. Lerner AB, Case JD. Melatonin. Fed Proc 1960;19:590-2.
37. Haimov I, Laudon M, Zisapel N, et al. Sleep disorders and melatonin rhythm in elderly people. BMJ 1994;309:167.
38. Tzischinsky O, Shlitner A, Lavie P. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin. J Biol Rhythms 1993;8:199-209.
39. Cramer H, Rudolph J, Consbruch U, Kendel K. On the effects of melatonin on sleep and behavior in man. In: Costa E, Gessa GL, Sandler M, eds. Advances in biochemical psychopharmacology. Vol. 11. Serotonin -new vistas: biochemistry and behavioral and clinical studies. New York: Raven Press, 1974:187-91.
40. Vollrath L, Semm P, Gammel G. Sleep induction by intranasal application of melatonin. Adv Biosci 1981;29:327-9.
41. Lieberman HR, Waldhauser F, Garfield G, Lynch HJ, Wurtman RJ. Effects of melatonin on human mood and performance. Brain Res 1984; 323:201-7.
42. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD. Delayed sleep phase syndrome response to melatonin. Lancet 1991;337:1121-4.
43. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18:598-603.
44. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346:541-4.
45. Oldani A, Ferini-Strambi L, Zucconi M, Stankov B, Fraschini F, Smirne S. Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation. Neuroreport 1994;6:132-4.
46. Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-8.
47. Wurtman RJ, Zhdanova I. Improvement of sleep quality by melatonin. Lancet 1995;346:1491.
48. Tzischinsky O, Lavie P. Melatonin possesses time-dependent hypnotic effects. Sleep 1994;17:638-45.
49. Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993;15:1-12.
50. Cagnacci A, Elliott JA, Yen SSC. Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab 1992;75:447-52.
51. Deacon S, Arendt J. Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in dose-dependent manner in humans. Brain Res 1995;688:77-85.
52. Arendt J, Aldhous M, Marks V. Alleviation of jet lag by melatonin: preliminary results of controlled double blind trial. BMJ 1986;292:1170.
53. Waldhauser F, Vierhapper H, Pirich K. Abnormal circadian melatonin secretion in night-shift workers. N Engl J Med 1986;315:1614.
54. Lewy AJ, Newsome DA. Different types of melatonin circadian secretory rhythms in some blind subjects. J Clin Endocrinol Metab 1983;56: 1103-7.
55. Lewy AJ, Sack RL, Blood ML, Bauer VK, Cutler NL, Thomas KH. Melatonin marks circadian phase position and resets the endogenous circadian pacemaker in humans. Ciba Found Symp 1995;183:303-17.
56. Petrie K, Dawson AG, Thompson L, Brook R. A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatry 1993;33:526-30.
57. Brown RP, Kocsis JH, Caroff S, et al. Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patients. Acta Psychiatr Scand 1987;76:272-5.
58. Blehar MC, Rosenthal NE. Seasonal affective disorders and phototherapy: a report of a National Institute of Mental Health-sponsored workshop. Arch Gen Psychiatry 1989;46:469-74.
59. Wirz-Justice A, Graw P, Krauchi K, et al. Light therapy in seasonal affective disorder is independent of time of day or circadian rhythm. Arch Gen Psychiatry 1993;50:929-37.
60. Reiter RJ. The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1980;1:109-31.
61. Rojansky N, Brzezinski A, Schenker JG. Seasonality in human reproduction: an update. Hum Reprod 1992;7:735-45.
62. Kauppila A, Kivela A, Pakarinen A, Vakkuri O. Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. J Clin Endocrinol Metab 1987; 65:823-8.
63. Heubner O. Tumor der glandula pinealis. Dtsch Med Wochenschr 1898;24:214.
64. Cavallo A, Ritschel WA. Pharmacokinetics of melatonin in human sexual maturation. J Clin Endocrinol Metab 1996;81:1882-6.
65. Waldhauser F, Boepple PA, Schemper M, Mansfield MJ, Crowley WF Jr. Serum melatonin in central precocious puberty is lower than age-matched prepubertal children. J Clin Endocrinol Metab 1991;73:793-6.
66. Puig-Domingo M, Webb SM, Serrano J, et al. Melatonin-related hypogonadotropic hypogonadism. N Engl J Med 1992;327:1356-9.
67. Brzezinski A, Lynch HJ, Seibel MM, Deng MH, Nader TM, Wurtman RJ. The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrheic women. J Clin Endocrinol Metab 1988;66: 891-5.
68. Brzezinski A, Cohen M, Ever-Hadani P, Mordel N, Schenker JG, Laufer N. The pattern of serum melatonin levels during ovarian stimulation for in vitro fertilization. Int J Fertil Menopausal Stud 1994;39:81-5.
69. Berga SL, Mortola JF, Yen SSC. Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1988;66:242-4.
70. Laughlin GA, Loucks AB, Yen SSC. Marked augmentation of nocturnal melatonin secretion in amenorrheic athletes, but not in cycling athletes: unaltered by opioidergic or dopaminergic blockade. J Clin Endocrinol Metab 1991;73:1321-6.
71. Luboshitzky R, Lavi S, Thuma I, Lavie P. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 1996;81:770-4.
72. Voordouw BCG, Euser R, Verdonk RER, et al. Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 1992;74:108-17.
73. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 1987;64:865-7.
74. Webley GE, Luck MR. Melatonin directly stimulates the secretion of progesterone by human and bovine granulosa cells in vitro. J Reprod Fertil 1986;78:711-7.
75. Van Coevorden A, Mockel J, Laurent E, et al. Neuroendocrine rhythms and sleep in aging men. Am J Physiol 1991;260:E651-E661.
76. Reiter RJ. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol 1995;30:192-212.
77. Dilman VM, Anisimov VN, Ostroumova M, Khavinson VK, Morozov VG. Increase in the lifespan of rats following polypeptide pineal extract. Exp Pathol 1979;17:539-45.
78. Pierpaoli W, Regelson W. Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci U S A 1994;91:787-91.
79. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B. Melatonin inhibition and pinealectomy enhancement of 7,12-demethyl-benz(a)anthracene-induced mammary tumors in the rat. Cancer Res 1981; 41:4432-6.
80. Tamarkin L, Danforth D, Lichter A, et al. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 1982;216:1003-5.
81. Bartsch C, Bartsch H, Fuchs U, Lippert TH, Bellmann O, Gupta D. Stage-dependent depression of melatonin in patients with primary breast cancer: correlation with prolactin, thyroid stimulating hormone, and steroid receptors. Cancer 1989;64:426-33.
82. Bartsch C, Bartsch H, Schmidt A, Ilg S, Bichler KH, Fluchter SH. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations. Clin Chim Acta 1992;209:153-67.
83. Hill SM, Blask DE. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988;48:6121-6.
84. Ying SW, Niles LP, Crocker C. Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 1993;246:89-96.
85. Molis TM, Spriggs LL, Hill SM. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 1994;8:1681-90.
86. Lissoni P, Meregalli S, Nosetto L, et al. Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology 1996;53:43-6.
87. Lissoni P, Barni S, Meregalli S, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen alone. Br J Cancer 1995;71:854-6.
88. Gonzalez R, Sanchez A, Ferguson JA, et al. Melatonin therapy of advanced human malignant melanoma. Melanoma Res 1991;1:237-43.
89. Lissoni P, Barni S, Ardizzoia A, Tancini G, Conti A, Maestroni GM. A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer 1994;73:699-701.